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General spectroscopic techniques
NMR spectra were recorded in CDCl 3 or DMSO-d 6 at room temperature on a Bruker AC-300 spectrometer (300.13 MHz for 1 H and 75.47 MHz for 13 C). The spectra were referenced to residual solvent protons in the 1 H NMR spectra (7.26 and 2.50 ppm) and to solvent carbons in the 13 C NMR spectra (77.00 and 39.43 ppm). Carbon substitution degrees were established by distortionless enhancement by polarization transfer pulse sequences. A combination of correlation spectroscopy and heteronuclear single quantum coherence experiments was used for the assignment of 1 H and 13 C chemical shifts. IR spectra were measured as thin films between NaCl plates and KBr pellets for liquid and solid compounds, respectively, in a Nicolet Avatar 320 spectrometer. Electron-impact (EI) and fast atom bombardment (FAB) mass spectra (MS and HRMS) were carried out in a
Micromass VG Autospec spectrometer. Extinction coefficients were calculated in 100 mM sodium phosphate buffer, pH 7.4 (PB).
2. Spectroscopic characterization data of haptens m2 and s3 and intermediates of their synthesis (Scheme 1 in the article)
2-(3-(3-(2-Chloropyridin-4-yl)ureido)phenyl)acetic acid (4, hapten m2)
ESI-3 154 (86), 151 (100); HRMS: calcd for C 14 H 12 ClN 3 O 3 305.05672, found 305.05541; UV (PB), ε (280 nm) = 11.35 mM −1 cm −1 , ε (260 nm) = 28.19 mM −1 cm −1 . 3073, 3015, 2950, 1739, 1574, 1522, 1458, 1434, 1197, 1147, 873, 744, 3465, 3375, 3210, 3005, 2950, 1734, 1636, 1592, 1550, 1479, 1437, 1360, 1258, 1132, 981, 
3-((4-(3-Phenylureido)pyridin-2-yl)thio)propanoic acid (11, hapten s3)

2-(3-Methoxy-3-oxopropylthio)-4-nitropyridine N-oxide
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5-(4-(3-((4-Fluorophenyl)ureido)pyridin-2-yl)thio)pentanoic acid (15, hapten 4Fs5) 377.12094, found 377.12086.
5-(4-(3-((4-Fluorophenyl)ureido)pyridin-2-yl)thio)pentanoic acid (15, hapten 4Fs5). Hapten 4Fs5
was obtained by hydrolysis of the methyl ester moiety of compound 14 (62 mg, 0.16 mmol) with and H-2 and H-6 Ph), 7.07 (1H, dd, J = 5.7, 1.9 Hz, H-5 Py), 7.13 (2H, m, H-3 and H-5 Ph), 3.10 (2H, t, J = 6.6 Hz, H-5), 2.24 (2H, t, J = 6.6 Hz, H-2), 1.63 (4H, m, H-3 and H-4); 13 C NMR 
5-(4-((3-p-Tolylureido)pyridin-2-yl)thio)pentanoic acid (18, hapten 4Ms5)
Methyl 5- ((4-(3-p-tolylureido) 
5-((4-(3-p-Tolylureido)pyridin-2-yl)thio)pentanoic acid (18, hapten 4Ms5
Preparation of CPPU analogues thio-CPPU and BzClPyA
Scheme S2. Preparation of CPPU analogues thio-CPPU and BzClPyA 1-(2-Chloro-4-pyridyl)-3-phenylthiourea (21, thio-CPPU 
N-(2-Chloro-4-pyridyl)-2-phenylacetamide (23, BzClPyA)
2-phenylacetyl chloride (22, 202 µL, 1.52 mmol) was added to a solution containing 4-amino-2-chloropyridine (19, 98 mg, 0.76 mmol) and N,N'-diisopropil ethylamine (i(Pr) 2 NEt, 290 µL, 1.68 mmol) in anhydrous 1,2-dichloroethane (2.0 mL). The mixture was stirred at rt for 1.5 h under inert atmosphere, then the solvent was eliminated and the crude product was diluted with water and extracted three times with EtOAc. The combined organic layers were washed with brine, dried over Na 2 SO 4 , and concentrated under vacuum to obtained an oil that was purified by column chromatography, using CH 3 Cl as eluent, to afford pure BzClPyA (23, 155 mg, 82%) as a slightly colored oil.
ESI-9 1.6 Hz, H-3 Py), 7.34-7.21 (6H, m, H-5 Py and H-2/H-3/H-4/H-5/H-6 Ph), 3.67 (CH 2 O); 13 C NMR (CDCl 3 ), δ: 170.46 (CON), 152.12 (C-2-Py), 149.79 (C-6 Py), 147.34 (C-4 Py), 133. ESI-10
Preparation of protein conjugates
Immunizing conjugate. The active ester method was used to couple haptens m2 and s3 to bovine serum albumin (BSA). Typically, a 100 mM hapten solution was prepared in N,Ndimethylformamide (DMF) and mixed with 1 molar equivalent of N-hydroxysuccinimide and 1 molar equivalent of N,N'-dicyclohexylcarbodiimide also in DMF. Additional DMF was added to bring the final concentration of all reagents to 50 mM. The hapten was activated overnight at rt in amber vials. The day after, the reaction was centrifuged and the supernatant was collected. Next, 400 µL of activated m2 or s3 hapten solution was added drop wise to 2.0 mL of a 15 mg/mL BSA solution in 50 mM sodium carbonate-bicarbonate buffer, pH 9.6 (CB). The coupling reaction was incubated during 4 h at rt with moderate stirring. The initial hapten-to-protein molar ratio (MR) in the mixture was approximately 44:1. Finally, the conjugate was separated from uncoupled hapten by gel filtration on Sephadex G-25, using 100 mM sodium phosphate buffer, pH 4.4 (PB) as eluent. The degree of hapten-to-protein conjugation was measured spectrophotometrically. If conjugation occurred, the UV-vis spectrum of the conjugate was slightly different from that of the free protein.
Therefore, the final average hapten-to-protein MR was calculated from the absorbance value at 280 nm by assuming that the molar absorption of the hapten and the protein were the same for the free and the conjugated forms. The purified conjugate was diluted to 1.0 mg/mL with PB and stored at ESI-11 procedure. MRs were determined by UV spectrophotometry. A solution of each conjugate was prepared at a concentration of 1.0 mg/mL in PB containing 0.01% (w/v) thimerosal, and it was stored at −20 ºC for daily usage. The final MRs can be found in Table S1 . Hapten s3 was also coupled to OVA by the active ester method using an initial hapten-to-protein MR of 15:1.
Enzyme tracers. A 1/10 dilution of the activation mixture in DMF, prepared for the previous conjugates, was employed containing 0.5 µmol of the activated hapten. This dilution was added to 1.0 mL of a solution of horseradish peroxidase (HRP) in CB at a concentration of 2.2 mg/mL. The initial hapten-to-protein MR in the mixture was 10:1. The conjugation was incubated during 4 h and then the enzyme tracer was separated from the uncoupled hapten as described before. The final MR was calculated using, in this case, the absorbance values obtained at 400 nm and 280 nm. A working solution of the enzyme tracer was prepared in PBS containing 1% (w/v) BSA and 0.01% (w/v) thimerosal at a concentration of 0.5 mg/mL and was stored for its daily usage at 4 ºC. The remaining fraction was stored in elution buffer at −20 ºC. For the final MRs see Table S1 . Hapten s3 was also coupled to HRP by the active ester method using an initial hapten-to-protein MR of 10:1. were performed with the OVA-s5 conjugate. Using this strategy it was possible to stabilize 5 additional hybridomas (Table S2) .
ESI-13
Monoclonal antibody purification. Immunoglobulins were purified from late stationary phase culture supernatants by ammonium sulfate precipitation followed by affinity chromatography following the manufacturer's instructions. Stock solutions of every antibody were prepared in PBS containing 1% (w/v) BSA and 0.01% (w/v) thimerosal and they were stored at 4 ºC for daily usage.
The remaining volume was 2-fold precipitated with a saturated ammonium sulfate solution for its long-term conservation and it was stored at 4 ºC. a The combinations for antibodies inside the same cluster are indicated in bold-type letter. b τ ranges from −1 to 1, indicating the lowest and highest similarity, respectively.
